Status:
COMPLETED
Study to Evaluate the Efficacy of Adalimumab in Patients With Erosive Osteoarthritis of the Interphalangeal Finger Joints
Lead Sponsor:
University Hospital, Ghent
Conditions:
Erosive Osteo-Arthritis
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
Patients will be randomized into two groups (1/1) during one year: * 40 mg adalimumab subcutaneously (sc) every other week * placebo The effect on x-rays and clinical parameters will be evaluated.
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Clear erosive image on x-ray of at least one interphalangeal finger joint
Exclusion
Key Trial Info
Start Date :
May 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2009
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00296894
Start Date
May 1 2006
End Date
February 1 2009
Last Update
February 9 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ghent
Ghent, Belgium, 9000